Effect of imbalance and intracluster correlation coefficient in cluster randomization trials with binary outcomes when the available number of clusters is fixed in advance

In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provid...

Full description

Saved in:
Bibliographic Details
Published inContemporary clinical trials Vol. 30; no. 4; pp. 317 - 320
Main Authors Ahn, Chul, Hu, Fan, Skinner, Celette Sugg, Ahn, Daniel
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.07.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability ( κ) and the intracluster correlation coefficient ( ρ) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case ( κ = 1.0), i.e., equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group ( k ⁎) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group ( k ⁎) is at least 20 and the imbalance parameter ( κ) is at least 0.8. Empirical powers were close to the nominal level when ( ρ ≤ 0.02, κ ≥ 0.8, and k ⁎ = 10) or ( ρ ≤ 0.02, κ = 0.8, and k ⁎ = 20).
AbstractList In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability ( κ) and the intracluster correlation coefficient ( ρ) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case ( κ = 1.0), i.e., equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group ( k ⁎) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group ( k ⁎) is at least 20 and the imbalance parameter ( κ) is at least 0.8. Empirical powers were close to the nominal level when ( ρ ≤ 0.02, κ ≥ 0.8, and k ⁎ = 10) or ( ρ ≤ 0.02, κ = 0.8, and k ⁎ = 20).
In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability (kappa) and the intracluster correlation coefficient (rho) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case (kappa=1.0), i.e., equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group (k*) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group (k*) is at least 20 and the imbalance parameter (kappa) is at least 0.8. Empirical powers were close to the nominal level when (rho< or =0.02, kappa> or =0.8, and k*=10) or (rho< or =0.02, kappa=0.8, and k*=20).In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability (kappa) and the intracluster correlation coefficient (rho) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case (kappa=1.0), i.e., equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group (k*) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group (k*) is at least 20 and the imbalance parameter (kappa) is at least 0.8. Empirical powers were close to the nominal level when (rho< or =0.02, kappa> or =0.8, and k*=10) or (rho< or =0.02, kappa=0.8, and k*=20).
In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [ 1 ] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability ( κ ) and the intracluster correlation coefficient ( ρ ) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case ( κ = 1.0), i.e. , equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group ( k *) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group ( k *) is at least 20 and the imbalance parameter ( κ ) is at least 0.8. Empirical powers were close to the nominal level when ( ρ ≤ 0.02, κ ≥ 0.8, and k * = 10) or ( ρ ≤ 0.02, κ = 0.6, and k * = 20).
In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability (kappa) and the intracluster correlation coefficient (rho) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case (kappa=1.0), i.e., equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group (k*) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group (k*) is at least 20 and the imbalance parameter (kappa) is at least 0.8. Empirical powers were close to the nominal level when (rho< or =0.02, kappa> or =0.8, and k*=10) or (rho< or =0.02, kappa=0.8, and k*=20).
Abstract In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability ( κ ) and the intracluster correlation coefficient ( ρ ) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case ( κ = 1.0), i.e. , equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group ( k⁎ ) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group ( k⁎ ) is at least 20 and the imbalance parameter ( κ ) is at least 0.8. Empirical powers were close to the nominal level when ( ρ ≤ 0.02, κ ≥ 0.8, and k⁎ = 10) or ( ρ ≤ 0.02, κ = 0.8, and k⁎ = 20).
Author Hu, Fan
Ahn, Daniel
Skinner, Celette Sugg
Ahn, Chul
AuthorAffiliation a Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX
b Department of Statistical Science, Southern Methodist University, Dallas, TX
c Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX
AuthorAffiliation_xml – name: b Department of Statistical Science, Southern Methodist University, Dallas, TX
– name: c Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX
– name: a Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX
Author_xml – sequence: 1
  givenname: Chul
  surname: Ahn
  fullname: Ahn, Chul
  email: chul.ahn@utsouthwestern.edu
  organization: Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, United States
– sequence: 2
  givenname: Fan
  surname: Hu
  fullname: Hu, Fan
  organization: Department of Statistical Science, Southern Methodist University, Dallas, TX, United States
– sequence: 3
  givenname: Celette Sugg
  surname: Skinner
  fullname: Skinner, Celette Sugg
  organization: Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, United States
– sequence: 4
  givenname: Daniel
  surname: Ahn
  fullname: Ahn, Daniel
  organization: Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21538455$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19348965$$D View this record in MEDLINE/PubMed
BookMark eNqFUstu1DAUjVARfcAHsEHewG4GO-8IqRKqykOqxAJYW459zdwhsYvtDLS_1J_kpjMdQSXKKlZ8Xr73HGcHzjvIsueCLwUX9ev1Uuu0zDnvlrxYct48yo5EVXWLnBf84PYsFo0oy8PsOMY150Vd1dWT7FB0Rdl2dXWU3ZxbCzoxbxmOvRqU08CUMwxdCkoPU0wQmPYhwKASekdnsBY1gksEYneQQCQ_4vUWlAKqIbKfmFasR6fCFfNT0n4E-rkCAqzIZqNwUP0AzE1jTxoUYicXGUZm8RfMQZgymznX0-yxJVV4tvueZF_fnX85-7C4-PT-49nbi4Wu2jItjLG2EXVdGKgVtLzsdWn6QuW6FNoK6DnkAL01Rimoe96IlhemaFSlO960ujjJTre6l1M_gtEwj2KQlwFHeoj0CuXfNw5X8pvfyHy27RoSeLUTCP7HBDHJEaOGgaYLfoqybvKK8lUEfPGn097ibj8EeLkDqKjVYGnKGuMel4uqaMtqxjVbnA4-xgBWaky3q6CAOEjB5dwYuZbUGDk3RvJCUmOIKe4x9yEe4LzZcoC2sEEIMs590GAwUJmk8fgg-_QeWw_okJ73Ha4grv0UHK1XChlzyeXnucVziXnHOS_rjgS6fwv8x_w3278Hxw
CitedBy_id crossref_primary_10_1186_s13063_018_2835_9
crossref_primary_10_1371_journal_pone_0255389
crossref_primary_10_2105_AJPH_2017_303706
crossref_primary_10_1016_j_ahj_2016_01_014
Cites_doi 10.1111/j.1525-1497.2005.40115.x
10.1016/j.jclinepi.2003.12.013
10.1002/bimj.4710290212
10.1093/biomet/85.2.487
10.1002/sim.2733
10.1016/0895-4356(91)90084-M
ContentType Journal Article
Copyright 2009 Elsevier Inc.
Elsevier Inc.
2009 INIST-CNRS
Copyright_xml – notice: 2009 Elsevier Inc.
– notice: Elsevier Inc.
– notice: 2009 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.cct.2009.03.007
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1559-2030
EndPage 320
ExternalDocumentID PMC2716697
19348965
21538455
10_1016_j_cct_2009_03_007
S1551714409000469
1_s2_0_S1551714409000469
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA122330
– fundername: NHLBI NIH HHS
  grantid: R01 HL087768
– fundername: NCRR NIH HHS
  grantid: UL1 RR024982
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OL0
OZT
P-8
P-9
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UAP
Z5R
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c584t-ddff71663de6ae804bc4db3a2c41cf1eb0e2eebfddaae6b071803d37a5c9078c3
IEDL.DBID AIKHN
ISSN 1551-7144
1559-2030
IngestDate Thu Aug 21 18:27:27 EDT 2025
Mon Jul 21 11:27:33 EDT 2025
Mon Jul 21 05:35:22 EDT 2025
Mon Jul 21 09:17:18 EDT 2025
Tue Jul 01 04:15:41 EDT 2025
Thu Apr 24 23:00:30 EDT 2025
Fri Feb 23 02:24:18 EST 2024
Sun Feb 23 10:19:04 EST 2025
Tue Aug 26 16:33:03 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Intracluster correlation
Varying cluster size
sample size
Binary outcomes
Correlation coefficient
Correlation
Randomization
Statistical analysis
Prognosis
Sample size
Clinical trial
Cluster
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c584t-ddff71663de6ae804bc4db3a2c41cf1eb0e2eebfddaae6b071803d37a5c9078c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/2716697
PMID 19348965
PQID 67256635
PQPubID 23479
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2716697
proquest_miscellaneous_67256635
pubmed_primary_19348965
pascalfrancis_primary_21538455
crossref_citationtrail_10_1016_j_cct_2009_03_007
crossref_primary_10_1016_j_cct_2009_03_007
elsevier_sciencedirect_doi_10_1016_j_cct_2009_03_007
elsevier_clinicalkeyesjournals_1_s2_0_S1551714409000469
elsevier_clinicalkey_doi_10_1016_j_cct_2009_03_007
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-07-01
PublicationDateYYYYMMDD 2009-07-01
PublicationDate_xml – month: 07
  year: 2009
  text: 2009-07-01
  day: 01
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Contemporary clinical trials
PublicationTitleAlternate Contemp Clin Trials
PublicationYear 2009
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Skinner, Rawl, Moser (bib5) 2005; 20
Lunn, Davies (bib9) 1998; 85
Snedecor, Cochran (bib4) 1989
Taljaard, Donner, Klar (bib2) 2007; 26
Donner, Klar (bib1) 2000
Johnson, Kotz (bib8) 1969
Donner, Eliasziw (bib10) 1991; 44
Adams, Gulliford, Ukoumunne, Eldridge, Chinn, Campbell (bib6) 2004; 57
Pocock (bib3) 1983
Donner, Koval (bib7) 1987; 29
Adams (10.1016/j.cct.2009.03.007_bib6) 2004; 57
Johnson (10.1016/j.cct.2009.03.007_bib8) 1969
Taljaard (10.1016/j.cct.2009.03.007_bib2) 2007; 26
Lunn (10.1016/j.cct.2009.03.007_bib9) 1998; 85
Pocock (10.1016/j.cct.2009.03.007_bib3) 1983
Donner (10.1016/j.cct.2009.03.007_bib10) 1991; 44
Skinner (10.1016/j.cct.2009.03.007_bib5) 2005; 20
Donner (10.1016/j.cct.2009.03.007_bib1) 2000
Snedecor (10.1016/j.cct.2009.03.007_bib4) 1989
Donner (10.1016/j.cct.2009.03.007_bib7) 1987; 29
References_xml – volume: 26
  start-page: 2615
  year: 2007
  end-page: 2628
  ident: bib2
  article-title: Accounting for expected attrition in the planning of community intervention trials
  publication-title: Stat Med
– volume: 44
  start-page: 449
  year: 1991
  end-page: 455
  ident: bib10
  article-title: Methodology for inferences concerning familial correlations: a review
  publication-title: J Clin Epidemiol
– year: 2000
  ident: bib1
  article-title: Design and analysis of cluster randomization trials in health research
– year: 1969
  ident: bib8
  article-title: Distributions in Statistics. Discrete Distributions
– year: 1989
  ident: bib4
  article-title: Statistical methods
– year: 1983
  ident: bib3
  article-title: Clinical Trials: A practical approach
– volume: 85
  start-page: 487
  year: 1998
  end-page: 490
  ident: bib9
  article-title: A Note on Generating Correlated Binary Variables
  publication-title: Biometrika
– volume: 29
  start-page: 181
  year: 1987
  end-page: 187
  ident: bib7
  article-title: A procedure for generating group sizes from a one-way classification with a specified degree of imbalance
  publication-title: Biom J
– volume: 20
  start-page: 360
  year: 2005
  end-page: 365
  ident: bib5
  article-title: Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy
  publication-title: J Gen Intern Med
– volume: 57
  start-page: 785
  year: 2004
  end-page: 794
  ident: bib6
  article-title: Pattern of intra-cluster correlation from primary care research to inform study design and analysis
  publication-title: J Clin Epidemiol
– year: 1969
  ident: 10.1016/j.cct.2009.03.007_bib8
– year: 2000
  ident: 10.1016/j.cct.2009.03.007_bib1
– volume: 20
  start-page: 360
  year: 2005
  ident: 10.1016/j.cct.2009.03.007_bib5
  article-title: Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy
  publication-title: J Gen Intern Med
  doi: 10.1111/j.1525-1497.2005.40115.x
– year: 1983
  ident: 10.1016/j.cct.2009.03.007_bib3
– year: 1989
  ident: 10.1016/j.cct.2009.03.007_bib4
– volume: 57
  start-page: 785
  year: 2004
  ident: 10.1016/j.cct.2009.03.007_bib6
  article-title: Pattern of intra-cluster correlation from primary care research to inform study design and analysis
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2003.12.013
– volume: 29
  start-page: 181
  year: 1987
  ident: 10.1016/j.cct.2009.03.007_bib7
  article-title: A procedure for generating group sizes from a one-way classification with a specified degree of imbalance
  publication-title: Biom J
  doi: 10.1002/bimj.4710290212
– volume: 85
  start-page: 487
  year: 1998
  ident: 10.1016/j.cct.2009.03.007_bib9
  article-title: A Note on Generating Correlated Binary Variables
  publication-title: Biometrika
  doi: 10.1093/biomet/85.2.487
– volume: 26
  start-page: 2615
  year: 2007
  ident: 10.1016/j.cct.2009.03.007_bib2
  article-title: Accounting for expected attrition in the planning of community intervention trials
  publication-title: Stat Med
  doi: 10.1002/sim.2733
– volume: 44
  start-page: 449
  year: 1991
  ident: 10.1016/j.cct.2009.03.007_bib10
  article-title: Methodology for inferences concerning familial correlations: a review
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(91)90084-M
SSID ssj0036565
Score 1.8444028
Snippet In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner...
Abstract In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 317
SubjectTerms Binary outcomes
Biological and medical sciences
Cardiovascular
Clinical trial. Drug monitoring
Cluster Analysis
Computerized, statistical medical data processing and models in biomedicine
Data Interpretation, Statistical
Epidemiology
General aspects
General pharmacology
Hematology, Oncology and Palliative Medicine
Humans
Intracluster correlation
Medical sciences
Medical statistics
Methodology
Models, Statistical
Pharmacology. Drug treatments
Public health. Hygiene
Public health. Hygiene-occupational medicine
Randomized Controlled Trials as Topic - methods
sample size
Varying cluster size
Title Effect of imbalance and intracluster correlation coefficient in cluster randomization trials with binary outcomes when the available number of clusters is fixed in advance
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1551714409000469
https://www.clinicalkey.es/playcontent/1-s2.0-S1551714409000469
https://dx.doi.org/10.1016/j.cct.2009.03.007
https://www.ncbi.nlm.nih.gov/pubmed/19348965
https://www.proquest.com/docview/67256635
https://pubmed.ncbi.nlm.nih.gov/PMC2716697
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3ZbtQw0OohISSEuAnH4geekMIm8ZHksVpRLUcrBFTqm-XYjjbVNlmRbNUnfoifZCZxFhZKkXiLkpnYnpmMx5mLkJdCWMFkyULD4jLkmbFhnuss1InV0piI8T6I5uhYzk_4u1NxukNmYy4MhlV63T_o9F5b-ztTT83pqqqmn3GzT9E3mfcpkPku2U9YLkG09w_evp8fjwqZgcki-rKpIg4RYXRu9mFexnS-aiWWOk3_tj3dWukWiFYO3S6uMkd_j6r8ZZs6vENue_uSHgxLuEt2XH2P3DjyHvT75PtQrpg2Ja3OC4xrNI7q2tIKX2eWayycQA327Bii5ODa9WUmYDwAoiMITNE25z6Lk_bNP1qKf3Vp0af40mbdAVEd3Fw4AFjAMBe6WmKqFh36kOAk_OtaWrW0rC4dToT6wIQH5OTwzZfZPPQNG0IDdkwXWluWcP6SzDqpXRbxwnBbMJ0YHpsydkXkEueK0lqtnSzAuskiZlmqhYEzembYQ7JXN7V7TGhaGDj6SCQJw-RdzQuW4y9sl1mRpTYg0cgnZXw1c2yqsVRj2NqZAtZil81cRUwBawPyaoOyGkp5XAecjMxXY44qaFUFG811SOlVSK71eqFVsWoTFak_ZDcgfIO5Jf7_GnCyJZebdSW4kXEhAvJiFFQFegOdQbp2zbpVMgVjF6zNgDwaxPYnTXLGs1zCk3RLoDcAWJF8-0ldLfrK5AlyP0-f_N9qnpKbg68Og6Gfkb3u69o9B5OvKyZk9_W3eAIf9uzTh48T_4H_AAR3XUk
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtQw0CpFAiSEeDc8Wh84IYVNYjuPI6qoFuj2Qiv1ZvkVbdA2WTVZxIkf4ieZSZzAQikStygZx_bMeDz2vAh5JYQVLC1ZaFhchjw3NiwKlYcqsSo1JmK8d6JZnKTzM_7hXJzvkMMxFgbdKr3sH2R6L639m5nH5mxdVbNPuNlnaJss-hDI4ga5yWH54up8823y82CgsIg-aaqIQwQfTZu9k5cxnc9ZiYlOs79tTnfXqgWUlUOti6uU0d99Kn_ZpI7uk3teu6Rvhwk8IDuufkhuLbz9_BH5PiQrpk1JqwuNXo3GUVVbWuHvzGqDaROowYodg48cPLs-yQT0B0B0BIEh2ubCx3DSvvRHS_FOl-o-wJc2mw5Q6uDl0gHAErr5oqoVBmrRoQoJDsL_rqVVS8vqq8OBUO-W8JicHb07PZyHvlxDaECL6UJryxJOXymzLlUuj7g23GqmEsNjU8ZORy5xTpfWKuVSDbpNHjHLMiUMnNBzw56Q3bqp3R6hmTZw8EkRJQxDdxXXrMALbJdbkWc2INFIJ2l8LnMsqbGSo9PaZwmkxRqbhYyYBNIG5PXUZD0k8rgOOBmJL8cIVZCpEraZ6xplVzVyrZcKrYxlm8hI_sG5AeFTyy3m_1eH-1t8Oc0rwW2MCxGQg5FRJUgNNAWp2jWbVqYZqLqgawbk6cC2P3FSMJ4XKXzJthh6AsB85Ntf6mrZ5yVPkPpF9uz_ZnNAbs9PF8fy-P3Jx-fkzmC1Q7foF2S3u9y4l6D8dXq_X9w_AA67XHg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Imbalance+and+Intracluster+Correlation+Coefficient+in+Cluster+Randomization+Trials+with+Binary+Outcomes+When+the+Available+Number+of+Clusters+is+Fixed+in+Advance&rft.jtitle=Contemporary+clinical+trials&rft.au=Ahn%2C+Chul&rft.au=Hu%2C+Fan&rft.au=Skinner%2C+Celette+Sugg&rft.au=Ahn%2C+Daniel&rft.date=2009-07-01&rft.issn=1551-7144&rft.eissn=1559-2030&rft.volume=30&rft.issue=4&rft.spage=317&rft.epage=320&rft_id=info:doi/10.1016%2Fj.cct.2009.03.007&rft_id=info%3Apmid%2F19348965&rft.externalDocID=PMC2716697
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15517144%2FS1551714409X00042%2Fcov150h.gif